Military Documents About Gain of Function Contradict Fauci Testimony Under Oath

excalibur

Diamond Member
Mar 19, 2015
22,753
44,324
2,290
Doing the work the MSM either won't do or tries to cover up.


...

Project Veritas has obtained a separate report to the Inspector General of the Department of Defense written by U.S. Marine Corp Major, Joseph Murphy, a former DARPA Fellow.

The report states that EcoHealth Alliance approached DARPA in March 2018, seeking funding to conduct gain of function research of bat borne coronaviruses. The proposal, named Project Defuse, was rejected by DARPA over safety concerns and the notion that it violates the basis gain of function research moratorium.

According to the documents, NIAID, under the direction of Dr. Fauci, went ahead with the research in Wuhan, China and at several sites across the U.S.

Dr. Fauci has repeatedly maintained, under oath, that the NIH and NAIAD have not been involved in gain of function research with the EcoHealth Alliance program. But according to the documents obtained by Project Veritas which outline why EcoHealth Alliance’s proposal was rejected, DARPA certainly classified the research as gain of function.

“The proposal does not mention or assess potential risks of Gain of Function (GoF) research,” a direct quote from the DARPA rejection letter.

Major Murphy’s report goes on to detail great concern over the COVID-19 gain of function program, the concealment of documents, the suppression of potential curatives, like Ivermectin and Hydroxychloroquine, and the mRNA vaccines.

...


 
This is too late in the chron.. One must go further back to Baric's Chapel Hill lab, because Baric was working with a virus that Eco Health Alliance's Daszak collected in Ap 2011 on the outskirts of Kunming, Yunnan. That virus was RsSHC014. The following report states that it was Wuhan bat lady Zheng-li Shi who gave the researchers RsSHC014, but is not correct. Daszak co-authored the published collection report of 18 Ap 2011:

'....In vivo experiments at Chapel Hill replicated the chimeric virus SHC014-MA15 (mouse-adapted) in mouse lung which showed significant pathogenesis which was the opposite of what the team expected ("the creation of chimeric viruses like SHC014-MA-15 was not expected to increase pathogenicity"). Manachery et al (2015) reported that it may be hard to develop a vaccine against SHC014-MA-15.

We can see therefore, that the 2015 experiment advanced the 2010 work by perfecting in animal trials a virus optimized to infect the human upper respiratory tract. The 2015 authors were well aware that the chimeric virus which they had created was very dangerous because they discussed this fact....The paper states that this research consortium has permission to continue this research.'
 

Forum List

Back
Top